FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1237358001: Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Aug 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5097894011 Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5097895012 Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5259832012 Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5097894011 Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5097895012 Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5259832012 Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Is a Levocetirizine and montelukast only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has manufactured dose form Tablet for conventional release oral suspension (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has precise active ingredient Montelukast sodium true Inferred relationship Existential restriction modifier (core metadata concept) 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has basis of strength substance (attribute) Montelukast (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has precise active ingredient Levocetirizine dihydrochloride (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has basis of strength substance (attribute) Levocetirizine dihydrochloride (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg dispersible oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start